Showing results (261-270 of 289) with videos related to
Sort By:
Pageof 29
Urologic Oncology|January 13, 2011
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinomaK T Ow, H Mameghan, A Lochhead, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Raghavan, V Harvey, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancerJ F Bishop, R Kefford, D Raghavan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancerJ F Bishop, D Raghavan, R Stuart-Harris, et al.American Journal of Public Health|September 1, 1986
Affirmative action at work: a survey of graduates of the University of California, San Diego, Medical SchoolN E Penn, P J Russell, H J Simon, et al.British Journal of Urology|November 1, 1993
Oral cyclophosphamide for the management of hormone-refractory prostate cancerD Raghavan, K Cox, B S Pearson, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigenK Wester, E Wahlund, C Sundström, et al.British Journal of Cancer|August 26, 2010
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progressionJ Hao, H Chen, M C Madigan, et al.International Journal of Cancer|September 29, 2000
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targetsJ L Yang, D q Seetoo, Y Wang, et al.British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.Pageof 29